The use of oral antidiabetic medications in gestational diabetes mellitus

被引：0
作者：
Paglia M.J. [1 ]
Coustan D.R. [1 ]
机构：
[1] Warren Alpert School of Medicine, Brown University, Women and Infants Hospital, Providence, RI 02905
来源：
Current Diabetes Reports | 2009年 / 9卷 / 4期
关键词：
Metformin; Hypoglycemia; Gestational Diabetes Mellitus; Obstet Gynecol; Sulfonylurea;
D O I：
10.1007/s11892-009-0044-3
中图分类号：
学科分类号：
摘要：
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance with onset or first recognition during pregnancy. When medical nutrition therapy is not successful in maintaining target glucose values during pregnancy complicated by GDM, medication is required. Insulin has been the traditional treatment under such circumstances. The use of oral antidiabetic medications in the management of gestational diabetes has increased over the past several years. Recent studies have shown the equivalence to insulin of both glyburide and metformin in terms of pregnancy outcomes in GDM. However, both agents have been shown to cross the placenta to the fetus, and thus they should be used with caution and patients counseled appropriately. © Current Medicine Group, LLC 2009.
引用
收藏
页码：287 / 290
页数：3
相关论文
共 23 条
  • [1] Hunt K.J., Schuller K.L., The increasing prevalence of diabetes in pregnancy, Obstet Gynecol Clin North Am, 34, pp. 173-199, (2007)
  • [2] Langer O., Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus, Diabetes Care, 21, SUPPL. 2, (1998)
  • [3] Langer O., Rodriguez D.A., Xenakis E.M., Et al., Intensified vs. conventional management of gestational diabetes, Am J Obstet Gynecol, 170, pp. 1036-1047, (1994)
  • [4] Crowther C.A., Hiller J.E., Moss J.R., Et al., Effect of treatment of gestational diabetes mellitus on pregnancy outcomes, N Engl J Med, 352, pp. 2477-2486, (2005)
  • [5] American Diabetes Association: Gestational diabetes mellitus, Diabetes Care, 27, SUPPL. 1, (2004)
  • [6] Gestational Diabetes: ACOG Practice Bulletin No. 30, Obstet Gynecol, 98, pp. 525-538, (2001)
  • [7] DeFronzo R.A., Simonson D.C., Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals, Diabetes Care, 7, pp. 724-727, (1984)
  • [8] Rossetti L., Giaaccari A., DeFronzo R.A., Glucose toxicity, Diabetes Care, 13, pp. 610-630, (1990)
  • [9] Simonson D.C., Farrannini E., Bevilacqua S., Et al., Mechanism of improvement in glucose metabolism after chronic glyburide therapy, Diabetes Care, 33, pp. 838-845, (1984)
  • [10] Elliot B., Langer O., Schenker S., Johnson R.F., Insignificant transfer of glyburide occurs across the human placenta, Am J Obstet Gynecol, 165, pp. 807-812, (1991)
123